To further explore the influence of MTA2 on cell proliferation, we determined whether MTA2 knockdown had a cytotoxic effect on RCC cells using an (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide; MTT) MTT assay. The gene discussed is MTA2; the disease is renal cell carcinoma.